Synermore is a Taiwan based biotech company focused on the research and development of innovative and biosimilar monoclonal antibodies in the areas of oncology, infectious diseases, and immune disorders. The core competence is to bring products from research stage through IND-enabling nonclinical and CMC activities to clinical stage of development.